Literature DB >> 12437480

Murine pharmacogenomics: using the mouse to understand the genetics of drug therapy.

James W Watters1, Howard L McLeod.   

Abstract

Pharmacogenomics seeks to understand the genetic basis of interindividual differences in drug disposition and effects. Differential drug response is likely to most often be a complex trait, in which multiple genes contribute with varying strengths to the therapeutic phenotype. Due to technical and economic limitations, pharmacogenomic studies in humans are mainly limited to a small number of candidate genes with relatively major influences on drug response. This review discusses the problems involved in mapping genes underlying drug response in humans and highlights the theoretical and applied uses of mouse genetics to address these important issues.

Entities:  

Mesh:

Year:  2002        PMID: 12437480     DOI: 10.1517/14622416.3.6.781

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  3 in total

Review 1.  Pharmacogenomics and drug development.

Authors:  Yingying Guo; Steven Shafer; Paul Weller; Jonathan Usuka; Gary Peltz
Journal:  Pharmacogenomics       Date:  2005-12       Impact factor: 2.533

2.  A framework for comparing phenotype annotations of orthologous genes.

Authors:  Olivier Bodenreider; Anita Burgun
Journal:  Stud Health Technol Inform       Date:  2010

3.  Genetic variation in coding regions between and within commonly used inbred rat strains.

Authors:  Bart M G Smits; Bert F M van Zutphen; Ronald H A Plasterk; Edwin Cuppen
Journal:  Genome Res       Date:  2004-07       Impact factor: 9.043

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.